We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The FDA’s experiment in whether it can publish the clinical trials data behind drug approvals attracted a lone volunteer and now the agency is seeking public comment on whether they should stick with the project or try something else.